首页> The Lancet. Oncology> Short-course hypofractionated proton beam therapy, incorporating <sup>18</sup>F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial.

Short-course hypofractionated proton beam therapy, incorporating <sup>18</sup>F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial.

导出原文传递

翻译打印收藏纠错

第一作者： Sujay,Vora

第一单位： Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA. Electronic address: vora.sujay@mayo.edu.

作者： Sujay,Vora ^[1] ; Deanna,Pafundi ^[2] ; Molly,Voss ^[3] ; Matthew,Buras ^[3] ; Jonathan,Ashman ^[4] ; Bernard,Bendok ^[5] ; William,Breen ^[6] ; Leland,Hu ^[7] ; Sani,Kizilbash ^[8] ; Nadia,Laack ^[6] ; Wei,Liu ^[4] ; Anita,Mahajan ^[6] ; Maciej,Mrugala ^[9] ; Alyx,Porter ^[9] ; Michael,Ruff ^[10] ; Terence,Sio ^[4] ; Joon,Uhm ^[10] ; Ming,Yang ^[11] ; Debra,Brinkmann ^[6] ; Paul,Brown ^[6]

作者单位： Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA. Electronic address: vora.sujay@mayo.edu. ^[1] Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA. ^[2] Division of Clinical Trials and Biostatistics, Mayo Clinic, Phoenix, AZ, USA. ^[3] Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA. ^[4] Department of Neurologic Surgery, Mayo Clinic, Phoenix, AZ, USA. ^[5] Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA. ^[6] Division of Neuroradiology, Mayo Clinic, Phoenix, AZ, USA. ^[7] Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA. ^[8] Department of Neurology, Mayo Clinic, Phoenix, AZ, USA. ^[9] Division of Neuro-Oncology, Mayo Clinic, Rochester, MN, USA. ^[10] Division of Nuclear Medicine, Mayo Clinic, Phoenix, AZ, USA. ^[11]